Release Date: 15/09/20 10:09 Summary: Revised OPC offer and Relevant Interest Price Sensitive: Yes Download Document 2.31MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%